These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30920963)

  • 21. Detection of estrogen receptor in paraffin-embedded sections of breast carcinoma by immunohistochemistry and in situ hybridization.
    Graham DM; Jin L; Lloyd RV
    Am J Surg Pathol; 1991 May; 15(5):475-85. PubMed ID: 1852132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Histopathology; 2019 May; 74(6):917-924. PubMed ID: 30585668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry.
    Bingham V; Ong CW; James J; Maxwell P; Waugh D; Salto-Tellez M; McQuaid S
    Hum Pathol; 2016 Jan; 47(1):95-103. PubMed ID: 26518664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study.
    Hanna WM; Barnes PJ; Chang MC; Gilks CB; Magliocco AM; Rees H; Quenneville L; Robertson SJ; SenGupta SK; Nofech-Mozes S
    J Clin Oncol; 2014 Dec; 32(35):3967-73. PubMed ID: 25385731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.
    Kim C; Tang G; Pogue-Geile KL; Costantino JP; Baehner FL; Baker J; Cronin MT; Watson D; Shak S; Bohn OL; Fumagalli D; Taniyama Y; Lee A; Reilly ML; Vogel VG; McCaskill-Stevens W; Ford LG; Geyer CE; Wickerham DL; Wolmark N; Paik S
    J Clin Oncol; 2011 Nov; 29(31):4160-7. PubMed ID: 21947828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.
    Loi S; Dafni U; Karlis D; Polydoropoulou V; Young BM; Willis S; Long B; de Azambuja E; Sotiriou C; Viale G; Rüschoff J; Piccart MJ; Dowsett M; Michiels S; Leyland-Jones B
    JAMA Oncol; 2016 Aug; 2(8):1040-7. PubMed ID: 27100299
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further evidence to support bimodality of oestrogen receptor expression in breast cancer.
    Muftah AA; Aleskandarany M; Sonbul SN; Nolan CC; Diez Rodriguez M; Caldas C; Ellis IO; Green AR; Rakha EA
    Histopathology; 2017 Feb; 70(3):456-465. PubMed ID: 27648723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction.
    de Cremoux P; Bieche I; Tran-Perennou C; Vignaud S; Boudou E; Asselain B; Lidereau R; Magdelénat H; Becette V; Sigal-Zafrani B; Spyratos F
    Endocr Relat Cancer; 2004 Sep; 11(3):489-95. PubMed ID: 15369450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and
    Butler EN; Bensen JT; Chen M; Conway K; Richardson DB; Sun X; Geradts J; Olshan AF; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):67-74. PubMed ID: 29133365
    [No Abstract]   [Full Text] [Related]  

  • 31. Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma.
    Bhargava R; Lal P; Chen B
    Diagn Mol Pathol; 2004 Dec; 13(4):213-6. PubMed ID: 15538111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study.
    Memon R; Prieto Granada CN; Harada S; Winokur T; Reddy V; Kahn AG; Siegal GP; Wei S
    Clin Breast Cancer; 2022 Jan; 22(1):e123-e133. PubMed ID: 34120846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples.
    Wilson TR; Xiao Y; Spoerke JM; Fridlyand J; Koeppen H; Fuentes E; Huw LY; Abbas I; Gower A; Schleifman EB; Desai R; Fu L; Sumiyoshi T; O'Shaughnessy JA; Hampton GM; Lackner MR
    Breast Cancer Res Treat; 2014 Nov; 148(2):315-25. PubMed ID: 25338319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging.
    Causey MW; Huston LJ; Harold DM; Charaba CJ; Ippolito DL; Hoffer ZS; Brown TA; Stallings JD
    J Surg Res; 2011 Dec; 171(2):615-22. PubMed ID: 20655063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of AIB1 protein as a prognostic factor in breast cancer.
    Lee K; Lee A; Song BJ; Kang CS
    World J Surg Oncol; 2011 Oct; 9():139. PubMed ID: 22035181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-evaluation of HER2 status in 606 breast cancers-gene protein assay on tissue microarrays versus routine pathological assessment.
    Sandén E; Khazaei S; Tryggvadottir H; Borgquist S; Isaksson K; Jirström K; Jernström H
    Virchows Arch; 2020 Aug; 477(2):317-320. PubMed ID: 32080761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.
    Zeng J; Piscuoglio S; Aggarwal G; Magda J; Friedlander MA; Murray M; Akram M; Reis-Filho JS; Weigelt B; Edelweiss M
    Cancer Cytopathol; 2020 Feb; 128(2):133-145. PubMed ID: 31883437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "HER2 immunohistochemistry inter-observer reproducibility in 205 cases of invasive breast carcinoma additionally tested by ISH" Answer to the statistical issue to avoid misinterpretation.
    Casterá Redal C; Bernet Vegué L
    Ann Diagn Pathol; 2020 Oct; 48():151566. PubMed ID: 32763505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
    Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
    Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
    Lim SJ; Cantillep A; Carpenter PM
    Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.